Teladoc Health, Inc. Common Stock (TDOC)

EQNX::TICKER_START (OTCQB:AVAI),(NASDAQTEM),NYSE:MDTNYSEMDT)(NYSE:TDOCNYSETDOC,(NASDAQ:TALKNASDAQ) EQNX::TICKER_END

Eligible customers can now find and enroll in Teladoc Health’s cardiometabolic programs directly through Amazon

PURCHASE, NY, Jan. 06, 2025 (GLOBE NEWSWIRE) -- Teladoc Health, Inc. (NYSETDOC), the global leader in virtual care, announced today that Chuck Divita, chief executive officer, and Mala Murthy, chief financial officer, will participate in the 43rd Annual J.P. Morgan Healthcare Conference in San Francisco on Monday, January 13, 2025, at 4:30 p.m. PT (7:30 p.m. ET). A live audio webcast and replay of the presentation will be available at https://ir.teladochealth.com/news-and-events/events-and-presentations.

New artificial intelligence (AI) capabilities help hospitals and health systems deliver safer and more efficient care

PURCHASE, NY, Nov. 21, 2024 (GLOBE NEWSWIRE) -- Teladoc Health, Inc. (NYSETDOC), the global leader in whole-person virtual care, announced today that Chuck Divita, chief executive officer, and Mala Murthy, chief financial officer, will participate in the 36th Annual Piper Sandler Healthcare Conference in New York on Tuesday, December 3, 2024, at 12:30 p.m. ET. A live audio webcast and replay of the presentation will be available at http://ir.teladochealth.com/news-and-events/events-and-presentations/.

EQNX::TICKER_START (OTCQB:AVAI),(NYSETDOC),NASDAQ:TEMNASDAQTEM)(NYSE:MDTNYSEMDT,(NASDAQ:CLOVNASDAQ) EQNX::TICKER_END

PURCHASE, NY, Nov. 07, 2024 (GLOBE NEWSWIRE) -- Teladoc Health, Inc. (NYSETDOC), the global leader in whole-person virtual care, today announced that it issued inducement awards to two new employees.

PURCHASE, NY, Oct. 30, 2024 (GLOBE NEWSWIRE) -- Teladoc Health, Inc. (NYSETDOC), the global leader in whole-person virtual care, today reported financial results for the three months ended September 30, 2024 (“Third Quarter 2024”). Unless otherwise noted, percentage and other changes are relative to the three months ended September 30, 2023 (“Third Quarter 2023”).

PALM BEACH, Fla. , Nov. 20, 2024 (GLOBE NEWSWIRE) -- FN Media Group News Commentary - The Healthcare Artificial Intelligence (AI) market exhibits a high degree of innovation, characterized by ongoing advancements in technology. Rapid developments in ML, deep learning, NLP, and computer vision are driving the evolution of AI-powered healthcare solutions. One primary factor driving market growth is the increasing demand in the healthcare sector for enhanced efficiency, accuracy, and better patient outcomes. According to a March 2024 Microsoft-IDC study, 79% of healthcare organizations are presently utilizing AI technology. In addition, the return on investment (ROI) is realized within 14 months, generating USD 3.20 for every USD 1 invested in artificial intelligence (AI). AI technologies hold transformative potential in various areas including medical imaging analysis, predictive analytics, personalized treatment planning, and drug discovery, potentially transforming conventional healthcare practices. A report from Grand View Research said the global AI in healthcare market size, which was estimated at USD 19.27 billion in 2023, is expected to grow at a CAGR of 38.5% from 2024 to 2030. The report said: “Mergers & acquisitions (M&As) play a significant role in shaping the healthcare AI market landscape. Companies [that] engage in M&A activities to expand their AI software and services increase their market reach or acquire specialized technology and expertise. End-users are becoming increasingly aware of the potential benefits of AI in improving patient care, operational efficiency, and healthcare outcomes. Education initiatives and industry events helped raise awareness about the capabilities and applications of AI in healthcare.” A.I. companies active in the markets include: Avant Technologies Inc. (OTCQB: AVAI), Teladoc Health, Inc. (NYSETDOC), Tempus AI, Inc. NASDAQ: TEMNASDAQTEM)(NYSE: MDTNYSEMDT, Clover Health Investments, Corp. (NASDAQ: CLOVNASDAQ).

PURCHASE, NY, Oct. 16, 2024 (GLOBE NEWSWIRE) -- Teladoc Health Inc. (NYSETDOC), the global leader in whole-person virtual care, announced that it will release third quarter 2024 results on Wednesday, October 30, 2024, after the market closes. In conjunction, the company will host a conference call to review results at 4:30 p.m. E.T. on the same day.

PURCHASE, NY, Oct. 04, 2024 (GLOBE NEWSWIRE) -- Teladoc Health, Inc. (NYSETDOC), the global leader in whole-person virtual care, today announced that it issued inducement awards to three new employees.

PURCHASE, NY, Sept. 06, 2024 (GLOBE NEWSWIRE) -- Teladoc Health, Inc. (NYSETDOC), the global leader in whole-person virtual care, today announced that it issued an inducement award to a new employee.

Doximity Inc. (NYSEDOCS) is a digital professional medical networking platform that is a cross between LinkedIn and Meta Platforms Inc.

PURCHASE, NY, July 31, 2024 (GLOBE NEWSWIRE) -- Teladoc Health, Inc. (NYSETDOC), the global leader in whole-person virtual care, today reported financial results for the three months ended June 30, 2024 (“Second Quarter 2024”). Unless otherwise noted, percentage and other changes are relative to the three months ended June 30, 2023 (“Second Quarter 2023”).

Virtual healthcare provider Teladoc Health Inc. (NYSETDOC) stock is trading down 57.8% year-to-date (YTD). The collapse occurred after reporting Q4 2023

PURCHASE, NY, July 17, 2024 (GLOBE NEWSWIRE) -- Teladoc Health, Inc. (NYSETDOC), the global leader in whole-person virtual care, announced that it will release second quarter 2024 results on Wednesday, July 31, 2024, after the market closes. In conjunction, the company will host a conference call to review results at 4:30 p.m. E.T. on the same day.

Seamless access to a comprehensive range of mental healthcare options provides swift, early intervention and treatment for kids and teens, reduces caregiver stress, promotes healthy lifestyle habits at an early age

NEW YORK, July 13, 2024 (GLOBE NEWSWIRE) -- Bragar Eagel & Squire, P.C., a nationally recognized shareholder rights law firm, reminds investors that class actions have been commenced on behalf of stockholders of UnitedHealth Group Incorporated (NYSEUNH), Vestis Corporation NYSE: VSTSNYSEVSTS)(NYSE: TDOCNYSETDOC, and Direct Digital Holdings, Inc. (NASDAQ: DRCTNASDAQ). Stockholders have until the deadlines below to petition the court to serve as lead plaintiff. Additional information about each case can be found at the link provided.

Securities Litigation Partner James (Josh) Wilson Encourages Investors Who Suffered Losses In Teladoc To Contact Him Directly To Discuss Their Options

Unlock summer's hidden investment potential by exploring overlooked sectors that are poised for growth.

NEW YORK, July 09, 2024 (GLOBE NEWSWIRE) -- Bragar Eagel & Squire, P.C., a nationally recognized shareholder rights law firm, reminds investors that class actions have been commenced on behalf of stockholders of Sprout Social, Inc. (NASDAQSPT), UnitedHealth Group Incorporated NYSE: UNHNYSEUNH)(NYSE: VSTSNYSEVSTS, and Teladoc Health, Inc. (NYSE: TDOCNYSE). Stockholders have until the deadlines below to petition the court to serve as lead plaintiff. Additional information about each case can be found at the link provided.

PURCHASE, NY, July 08, 2024 (GLOBE NEWSWIRE) -- Teladoc Health, Inc. (NYSETDOC), the global leader in whole-person virtual care, today announced that it issued inducement awards to two new employees.

NEW YORK, July 05, 2024 (GLOBE NEWSWIRE) --

NEW YORK, July 04, 2024 (GLOBE NEWSWIRE) -- Bragar Eagel & Squire, P.C., a nationally recognized shareholder rights law firm, reminds investors that class actions have been commenced on behalf of stockholders of UnitedHealth Group Incorporated (NYSEUNH), Vestis Corporation NYSE: VSTSNYSEVSTS)(NYSE: TDOCNYSETDOC, and Direct Digital Holdings, Inc. (NASDAQ: DRCTNASDAQ). Stockholders have until the deadlines below to petition the court to serve as lead plaintiff. Additional information about each case can be found at the link provided.

Faruqi & Faruqi, LLP Securities Litigation Partner James (Josh) Wilson Encourages Investors Who Suffered Losses Exceeding $100,000 In Teladoc To Contact Him Directly To Discuss Their Options